Lin Zhao is an accomplished clinical research scientist and matrix team leader with over 20 years of experience in the pharmaceutical industry, specializing in all phases of drug development. They have held various leadership roles, including Executive Scientific Director at Amgen, where they lead global development for AMG329 targeting Sjogren's Disease, and previously served as Director at Astellas Pharma, focusing on immunology projects. Lin has demonstrated expertise in therapeutic areas such as immunology, cardiovascular, and metabolic diseases, with a strong record in strategic development and regulatory filing. Their educational background includes a PhD from the University of Montana and ongoing studies at China Pharmaceutical University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices